GSK announced the launch of Iodex Ultra Gel, a new age clinically proven gel-based body pain solution. According to a press release, the new Iodex Ultra Gel with emulgel formulation contains DiclofenacDiethylamine 1.16 per cent w/w, that penetrates deep to the source of pain to give effective relief. The product has modern sensorials like pleasant smell, non-greasy texture and cooling sensation, the release added.
Area marketing director, GSK, Naveed Ahmed said, ‘We are addressing the needs of these sets of consumers by launching Iodex Ultra Gel, a clinically proven formulation that will offer effective pain relief, making it one of the best pain solutions available in the market. We are confident that this launch will further augment consumer trust in the brand and help strengthen our topical pain relief portfolio.’